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The use of nanodiamonds (NDs) for medical applications is a subject of intensive 
research in recent years1. The bio-compatibility and the versatility of these nano 
size particles have made them attractive for potential applications in drug delivery, 
disease diagnosis, and targeted therapy. The most attractive feature of NDs is their 
capability to be functionalized by surface modification. Biomolecules and other 
functional groups can be easily attached to their surfaces chemically enabling 
them to load drugs, to target specific proteins and DNA sequences2, 3 performing 
specific tasks for different medical purposes. But most of the studies conducted so 
far are concentrated on the surfaces of NDs. People have not yet thought about 
how to modify the inside of these tiny particles for medical purposes. Although 
some of the defects or impurities introduced inside the NDs during the production 
processes can change some of the physical properties of NDs, they are difficult to 
be modified once they are produced because of the tight bonding of the carbon 
atoms. Recently we have developed a new technique using ion implantation to add 
impurities into the NDs. This technique allows us to alter the physical properties 
of NDs and adds a new dimension for their applications. Magnetic NDs have been 
produced by implanting Fe ions into the NDs. Excellent magnetic property has 
been demonstrated4. Using the magnetic properties of Fe doped NDs, we report in 
this paper the magnetic resonance imaging (MRI) capability of these NDs. Because 
the Fe atoms are embedded inside the NDs, the particles do not have cell toxicity. 
These particles can be monitored and used as an excellent contrast agent for MRI. 
The image enhancement properties of Fe doped NDs and the cell viability when 
they are used are reported for the first time. Combing the imaging capability of Fe 
doped NDs and their other functions, we foresee them a potential tool for 
performing drug delivery5, radio frequency thermal therapy6 and imaging at the 
same time. 
 
Magnetic resonance imaging (MRI) is a powerful tool in diagnosis of various diseases7, 
8. More and more advanced functions and techniques are being developed to enhance 
the capability of MRI. To get precise diagnosis, one needs clear, high-resolution and 
high-contrast MR images. One of the keys to achieve such images is to have a good 
contrast agent. The contrast agents that are commonly used today are either gadolinium 
(Gd) based complex9 or Fe based nanoparticles10. The magnetic properties of these 
materials enable them to enhance the MR images. However it has been shown that the 
Fe based contrast agents are toxic to living cells and therefore have been banned from 
clinical use for most of countries11. Today the most popular commercially available 
medical grade MRI contrast agents are Gd based complex. However they are not totally 
free of toxicity to human bodies12. Recently, the European Medicines Agency has 
decided to suspend the marketing authorization of some Gd based contrast agents used 
in body MRI scanning because of potential damages to the brain cells(7 July 2017 
EMA/424715 /2017).  
 
So what can we do? We need something that is both magnetic for MRI and at the same 
time nontoxic to human bodies. In this paper we demonstrate a nanoparticle based 
contrast agent that can do just that. Using the new technique we recently developed, we 
are able to dope NDs with Fe atoms using ion implantation. The accelerated Fe ions 
penetrate into the diamond particles and stay inside. We have shown in our recent study 
that these NDs possess excellent ferromagnetic property because of the presence of the 
Fe atoms4. Since NDs are known to be bio-compatible13, 14, 15, 16 and the toxic Fe atoms 
are inside the particles with no direct contact with the outside world, they are safe to 
living cells and tissues that are subject to this magnetic nanoparticles. These magnetic 
nanoparticles are responsive to external magnetic fields so they can work effectively as 
a contrast agent for MRI.  
 
Ion implantation is a common and popular technique used in the semiconductor 
industry. It puts desired impurity atoms into semiconductors to serve as active dopants 
providing the needed electrons and holes for device operations. It is proven that the 
atoms implanted into the semiconductors are stable and do not move in subsequent 
processes and during device operation. This point is very important since we intend to 
use this technique for medical purposes. The stability of the Fe atoms inside the NDs 
guarantees the safety of these nanoparticles for extended use in human bodies. NDs are 
being widely studied for medical applications17. They are not only nontoxic but also 
very versatile as they can be easily functionalized by attaching biomolecules to perform 
specific medical tasks, such as drug delivery18, cell labeling19 and targeted therapy20. In 
the past, there were also efforts trying to fabricate magnetic NDs for image 
enhancement and for localized thermal treatment. Gd-ND conjugates have been 
reported for MRI21. Magnetic NDs with Fe particles attached on the surface have also 
been reported22. But all these approaches used surface modification of the NDs. The 
toxicity associated with these magnetic materials can not be eliminated. The ion 
implantation process involves physical bombardment of Fe atoms onto the NDs. It is 
simple and straightforward and does not require any chemical processes.  
 
The effectiveness of these magnetic NDs as a contrast agent was studied using a Bruker 
MRI scanner (BIOSPEC 70/30 MRI). The DC magnetic field used was 7.0 Tesla. T2 
relaxation time was measured and the T2-weighted MR images were taken. The 
preparation procedure for the samples and other experimental parameters are described 
in the methods section. The 7.0 Tesla static magnetic field was first applied to polarize 
the spins of the water protons in the samples. As the net magnetization has been aligned 
with the static field, a radio frequency (RF) signal was applied to tip the magnetization 
towards the transverse direction. When the RF signal is removed, the net spin 
magnetization starts to relax back to the longitudinal direction. As the spins 
magnetization relax to their equilibrium state, the transverse component of the 
magnetization was monitored by a RF coil receiver. The transverse relaxation time 
constant, which is related to spin-spin interaction, is the so called T2.  
 
Two sets of samples were prepared. One set contained NDs without Fe and the other 
Fe doped NDs. The NDs were dissolved in DI water. Six samples in each set were 
prepared with NDs at different concentrations, which varied from 0 to 2.4 mg/ml. The 
measured T2 values for the samples are listed in Table 1. For samples with regular NDs, 
T2 drops slightly as the concentration increases. But for samples with Fe doped NDs, 
the T2 values were significantly shortened and had a strong dependence on the 
concentration. The efficiency of contrast enhancement of our samples was calculated 
based on the 1/T2 versus concentration relationship. The rate of change or slope of this 
relationship gives the relaxivity, r2, which is a measure of the contrast enhancement 
efficiency. Figure 1 shows the 1/T2 vs. concentration plots for the two sets of our 
samples. Very good straight line relationship was obtained. The calculated r2 for the 
regular NDs was 0.145 mls-1mg-1 but for the Fe doped NDs, this value jumps to 0.951 
mls-1mg-1. There is almost a seven times increase in r2 for the Fe doped NDs.  
 
The T2-weighted images of all samples are shown in Figure 2 (a). The images are 
obviously darker for samples with Fe doped NDs and the darkness intensifies as the 
concentration goes higher. The darkest image, the one with the lowest signal intensity, 
is clearly seen for the sample with the highest concentration of Fe doped NDs. We used 
the percentage of intensity enhancement defined as  
𝐼(𝑆𝑎𝑚𝑝𝑙𝑒) − 𝐼(𝐷𝐼 𝑤𝑎𝑡𝑒𝑟)
𝐼(𝐷𝐼 𝑤𝑎𝑡𝑒𝑟)
× 100% 
to quantify the image enhancement. These value are shown in the last column of Table 
1 and the data are plotted against the NDs concentration shown in Figure 2(b). For the 
sample with a concentration of 2.4 mg/ml Fe doped NDs, there is a staggering 78.5% 
enhancement in signal intensity compared to the DI water control sample. This extra 
contrast enhancement is resulted from the Fe atoms inside the NDs. The Fe atoms 
generate local magnetic field inhomogeneities. Water protons near Fe-doped NDs 
become dephased by the local field inhomogeneities and T2 is shortened because of the 
extra spin-spin interactions. This causes the image to become darker when Fe doped 
NDs are present in the sample.  
 
The cytotoxicity of the Fe doped NDs has also been studied. Cell viability test was 
carried out by MTT assay and the living cells were the NCTC cloned 929 cell line.  
Figure 3 is the result of this cell viability test. It is seen clearly Fe doped NDs have very 
little effect on the living cells. The difference between those of the regular NDs and the 
Fe doped ones is insignificant. The micrographs of the cells incubated with Fe doped 
NDs are shown in Figure 4. We can see that the living cells can grow normally with the 
presence of Fe-doped NDs. The safety of Fe doped NDs demonstrated here is of great 
importance for them to be used as a contrast agent in human bodies. It shows that the 
Fe atoms implanted inside the NDs without direct contact with the living cells are safe 
to the cells. This is very different from the conventional Fe based contrast agent, known 
as super paramagnetic iron oxide (SPIO). Because the iron oxides are in direct contact 
with the living tissues and can easily be released to the cells they are in contact with, 
and therefore are not free from toxicity. With high T2 relaxivity and ultralow cell 
toxicity, Fe doped NDs have the potential to be MRI contrast agents and are safe for 
the following bio-applications.  
 
In conclusion, we have demonstrated the capability of Fe doped magnetic NDs as 
contrast agents for MRI. The concentration dependent contrast enhancement and T2 
were studied. The T2 relaxivity, r2, is nearly seven times higher for Fe doped NDs 
compared with regular NDs. The Fe doping is obtained by ion implantation, which is 
simple and does not involve any chemical process. The cell viability test shows that the 
Fe atoms inside the NDs are safe for the living cells. The Fe doped magnetic NDs, when 
combined with other capabilities of NDs, are potentially useful for imaging, targeted 
cancer therapy, and localized treatment all at the same time. 
 
 
 
 
 
 
 
 
 
 
 
 
Methods. 
 
Fabrication of magnetic Fe doped magnetic nanodiamonds. 
 
ND powder (average 100nm in diameter, Microdiamant Co.) was first dissolved in 
deionized water (DI water). The solution was then applied onto an oxidized silicon 
wafer and dried. The wafer was Fe-ion implanted with an energy 150 keV and dose 
5x1015 atoms/cm2. The methods to remove the NDs from the Silicon wafer and to 
collect the implanted magnetic NDs have been described in our previous work4. 
 
Relaxivity Measurement and MR imaging 
 
Fe doped NDs were serially diluted with DI water to give five different sample 
concentrations (2.4, 1.2, 0.6, 0.3, and 0.15 mg/ml). Control samples were DI water and 
regular NDs with the same concentrations. All samples were contained in 0.3mL 
Eppendorf tubes, which were soaked in DI water to allow appropriate image acquisition. 
Bruker BIOSPEC 70/30 MRI scanner equipped with proper gradient coils was used. A 
multislice multiecho (MSME)-T2 map pulse sequence with fixed TR = 2700 ms, 60 
echoes in 11 ms intervals, matrix size = 256 x 256, field of view = 60 x 60 mm2, slice 
thickness = 1 mm, an average of 1 was used to measure the spin-spin relaxation 
times(T2) and capture T2-weighted images. The inverse of the transversal relaxation 
time of each sample (1/T2, s-1) was plotted against the concentration of Fe doped NDs 
and NDs. The relaxivity was extracted from the slope of linear regression curve. The 
shown T2-weighted image is the image from the 20th echo with TR = 2700 ms and TE 
= 649 ms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
MTT Assay using NCTC clone 929 cells 
 
The cytotoxicity effect of NDs and Fe-NDs on NCTC clone 929 cells was evaluated by 
using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
NDs and Fe-NDs samples were sterilized at 121℃ for 30 minutes. Before adding into 
cell culture, all samples were serial diluted with water and ultrasonic-treated for 30 
minutes. NCTC clone 929 cells were seeded in a 96-well flat bottom plate as 1104 
cell/well and incubated at 37℃ and 5% CO2. After overnight culture, NDs or Fe-NDs 
was added into medium individually with designed concentrations 0.24 mg/ml, 0.06 
mg/ml, 0.015 mg/ml, 0.00375 mg/ml, 0.00094 mg/ml, 0.00023 mg/ml and incubated for 
24 h. Water was added as control. To evaluate cell survival, 10 µl of MTT solution was 
added to each well and incubated for an additional 4 hours. Then the media was replaced 
with 100 µl of DMSO and mixed thoroughly to yield soluble formazan. The absorbance 
was then determined at 540 nm by ELISA reader and compared to the control solution 
to measure the cytotoxicity effect. All conditions were performed in triplicate. 
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Tables 
 
Table 1. T2 measurement results and MRI intensity enhancement for ND and Fe-ND 
samples. 
 
Sample Name Concentration(mg/ml) T2(ms) Enhancement(%) 
 
 
ND 
0(DI Water) 804.402±1.471 0 
0.15 785.833±1.484 -8.064 
0.3 764.908±1.278 -6.097 
0.6 741.179±1.390 -5.391 
1.2 699.064±1.149 -6.473 
2.4 623.116±1.137 -14.544 
 
 
Fe-ND 
0(DI Water) 804.402±1.471 0 
0.15 690.197±1.217 -22.394 
0.3 662.526±1.423 -23.266 
0.6 577.888±1.739 -32.149 
1.2 428.878±3.604 -53.063 
2.4 282.307±6.711 -78.516 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
 
Figure 1. The inverse of the transversal relaxation time (1/T2, s-1) against concentration 
plots of Fe-NDs and NDs samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2. (a) T2-weighted image of Fe-NDs and NDs samples. 1, 2.4 mg/ml Fe-NDs; 2, 
1.2 mg/ml Fe-NDs; 3, 0.6 mg/ml Fe-NDs; 4, 0.3 mg/ml Fe-NDs; 5, 0.15 mg/ml Fe-NDs; 
6, 2.4 mg/ml NDs; 7, 1.2 mg/ml NDs; 8, 0.6 mg/ml NDs; 9, 0.3 mg/ml NDs; 10, 0.15 
mg/ml NDs; 11, DI water. (b) MRI intensity plots of Fe-NDs and NDs samples. The 
intensity of DI water was used to be the intensity reference. 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(b) 
 Figure 3. Cytotoxicity effects of Fe-NDs and NDs on NCTC clone 929 cells by MTT 
test. Cell viability is compared to control and represented as mean ± SD. All conditions 
were done in triplicate. No significant cytotoxicity effects were observed at 
concentrations up to 0.24 mg/ml in ND and Fe-ND treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4. NCTC clone 929 Cell morphology under microscope after 24 hours Fe-ND 
treatment with different concentrations: (A) control (sterile water), (B) 0.00023 mg/ml, 
(C) 0.00094 mg/ml, (D) 0.00375 mg/ml, (E) 0.015 mg/ml, (F) 0.06 mg/ml, (G) 0.24 
mg/ml. Scale bar: 100 μm. 
